Avis De Sécurité sur DGP-HP RFA High-Power single use grounding pad and Cool-tip RFA Electrode Kits, Cool-tip RF System Electrode kits cluster, Cool-tip RF System Accessories

Selon ALIMS (Agencija za lekove i medicinska sredstva), ce/cet/cette avis de sécurité concerne un dispositif en/au/aux/à Serbia qui a été fabriqué par Covidien LP.

Qu'est-ce que c'est?

Les avis de sécurité sont des communications que les fabricants de dispositifs médicaux ou leurs représentants font parvenir en particulier aux travailleurs du secteur médical, mais aussi aux utilisateurs de ces dispositifs. Les avis de sécurité concernent les actions entreprises quant aux dispositifs présents sur le marché et peuvent inclure des rappels et des alertes.

En savoir plus sur les données ici
  • Type d'événement
    Field Safety Notice
  • Date de publication de l'événement
    2012-09-18
  • Pays de l'événement
  • Source de l'événement
    ALIMSA
  • URL de la source de l'événement
  • Notes / Alertes
    Serbian data is current through February 2018. All of the data comes from ALIMS (Agencija za lekove i medicinska sredstva), except for the categories Manufacturer Parent Company and Product Classification.
    The Parent Company and the Product Classification were added by ICIJ.
    The parent company information is based on 2017 public records. The device classification information comes from FDA’s Product Classification by Review Panel, based on matches of recall data from the U.S. and Serbia.
  • Notes supplémentaires dans les données
  • Cause
    The manufacturer has decided to implement a safety corrective measure in the field, ie withdrawal of the medical device from use, due to the risk posed on the grounding pad, which leads to degradation of the foil and release unwanted heat that can cause burns in patients. covidien received four reports of serious injuries, that is, burns at the location of the electrode pad. cool-type rf system accessories also contains grounding pads so that there is also the risk of an adverse reaction - burns.

Device

  • Modèle / numéro de série
    168583 - 213736X, 171281 - 215747X, 168576 - 214355X, 170882 - 214971X, 168571 - 213013X, 169419 - 220740, 168854 - 213368X, 168574 - 214434X, 169684 - 214973, 171300 - 208194X, 168575 - 215632, 168853 - 213703X, 170383 - 213699X, 169683 - 213042X, 169683 - 213042X, 170384 - 215746X, 184240 - 205456, 177906 - 214357X, 191404 - 205455, 162732 - 214867X
  • Manufacturer

Manufacturer

  • Société-mère du fabricant (2017)
  • Commentaire du fabricant
    “If our surveillance systems identify a potential performance issue, our personnel promptly evaluate the problem, including, when appropriate, conducting root cause investigations and internal testing to assess whether the product continues to meet specifications and defined performance criteria,” Medtronic told ICIJ in a statement. “In some cases, based on this evaluation, Medtronic may determine that a recall is necessary.” The company said that it communicates with healthcare providers and/or patients and provide recommendations to address such issues. Medtronic noted that these communications can include letters, emails, calls, press releases, physician notifications and social media postings, as well as informing the FDA and other regulators of the actions.
  • Source
    ALIMSA